Synlogic Granted FDA Fast Track Designation for SYNB1353 for the Treatment of Homocystinuria (HCU)GlobeNewsWire • 08/23/22
Synlogic, Inc. (SYBX) CEO Aoife Brennan on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/11/22
Synlogic Announces Synthetic Biotic for Gout Developed in Partnership with Ginkgo BioworksPRNewsWire • 08/11/22
Synlogic Reports Second Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 08/11/22
Synlogic Initiates Phase 1 Study of SYNB1353 for the Treatment of Homocystinuria (HCU)GlobeNewsWire • 07/12/22
Synlogic to Present at the 2022 HCU Network America, Organic Acidemia Association and Propionic Acidemia Foundation ConferenceGlobeNewsWire • 06/21/22
Synlogic, Inc. (SYBX) CEO Aoife Brennan on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/12/22
Synlogic Reports First Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 05/12/22
Synlogic Announces Data Presentations from Five Programs at the 2022 Synthetic Biology: Engineering, Evolution & Design (SEED) ConferenceGlobeNewsWire • 04/26/22
Synlogic to Present Data on Phenylketonuria and Homocystinuria Programs at the Society for Inherited Metabolic Disorders 43rd Annual MeetingGlobeNewsWire • 04/01/22
Synlogic, Inc. (SYBX) CEO Aoife Brennan on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/17/22
Synlogic Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business UpdateGlobeNewsWire • 03/17/22
Synlogic Announces Fourth Quarter and Full Year 2021 Conference Call and WebcastGlobeNewsWire • 03/10/22
Synlogic Presents Data Demonstrating Reductions in Plasma Phenylalanine Levels in Patients with Phenylketonuria Treated with SYNB1618PRNewsWire • 11/23/21
Synlogic, Inc. (SYBX) CEO Aoife Brennan on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/10/21
Synlogic Announces Presentation of Phenylketonuria Data at 14th International Congress of Inborn Errors of Metabolism MeetingPRNewsWire • 11/10/21
Synlogic and Ginkgo Bioworks Announce Investigational Synthetic Biotic Medicine for the Treatment of HomocystinuriaPRNewsWire • 11/09/21
Synlogic Announces Third Quarter 2021 Conference Call & Participation in Upcoming Banking ConferencePRNewsWire • 11/02/21